Spectroscopic and molecular modelling studies of Pt(II) complexes of tetrazole-5-thiol ligands and 1,2-Bis(diphenyl phosphino)ethane, and study the anticancer activity against HepG2 Liver cell line
DOI:
https://doi.org/10.54153/sjpas.2024.v6i3(2).859Keywords:
Pt(II), DFT, anti-cancer, HepG2, and Tetrazol thiol.Abstract
Two mixed ligand complexes of Pt(II) of 1-methyl-H1-tetrazole-5-thiol (Hmtz) or 1-phenyl-H1-tetrazole-5-thiol (Hptz) ligand and ,2-Bis(diphenyl phosphino)ethane (dppe) were prepared in one pot method. The prepared complexes were characterized using infrared spectroscopy (FTIR), molar conductivity, nuclear magnetic resonance ( 1H-NMR, and 31P-NMR). The results showed that the thiol ligand bonded as monodentate through the sulfur atom to afford square planar geometry. The prepared complexes were evaluated for their inhibitory activity against HepG2 liver cancer and showed good inhibitory activity. Further, the density functional theory (DFT) study was performed for the complexes and ligands using the B3LYP 6-31+G(d, p) functional for the ligands and the LanL2dz functional for complexes. It was found that the [Pt(mtz)2dppe] complex is more stable and chemically efficient than the [Pt(ptz)2dppe] complex through the study of quantum chemical parameters.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright Notice
Authors retain copyright and grant the SJPAS journal right of first publication, with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in Samarra Journal of Pure and Applied Science.
The Samarra Journal of Pure and Applied Science permits and encourages authors to archive Pre-print and Post-print items submitted to the journal on personal websites or institutional repositories per the author's choice while providing bibliographic details that credit their submission, and publication in this journal. This includes the archiving of a submitted version, an accepted version, or a published version without any Risks.